Exelixis Inc’s recent filing unveils that its Director Eckhardt Sue Gail unloaded Company’s shares for reported $0.81 million on Jun 02 ’25. In the deal valued at $42.74 per share,18,838 shares were sold. As a result of this transaction, Eckhardt Sue Gail now holds 21,380 shares worth roughly $0.81 million.
Then, WYSZOMIERSKI JACK L sold 7,535 shares, generating $324,683 in total proceeds. Upon selling the shares at $43.09, the Director now owns 358,882 shares.
Before that, JACK L WYSZOMIERSKI bought 7,535 shares. Exelixis Inc shares valued at $324,658 were divested by the Director at a price of $43.09 per share.
Guggenheim downgraded its Exelixis Inc [EXEL] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in late October from “a Market perform” to “an Outperform”.
Price Performance Review of EXEL
On Tuesday, Exelixis Inc [NASDAQ:EXEL] saw its stock fall -0.42% to $37.9. Over the last five days, the stock has lost -5.43%. Exelixis Inc shares have risen nearly 14.16% since the year began. Nevertheless, the stocks have risen 13.81% over the past one year. While a 52-week high of $49.62 was reached on 06/23/25, a 52-week low of $31.90 was recorded on 01/24/25.
Levels Of Support And Resistance For EXEL Stock
The 24-hour chart illustrates a support level at 37.35, which if violated will result in even more drops to 36.81. On the upside, there is a resistance level at 38.67. A further resistance level may holdings at 39.45.
How much short interest is there in Exelixis Inc?
A steep rise in short interest was recorded in Exelixis Inc stocks on 2025-10-15, growing by 3.29 million shares to a total of 20.88 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 17.59 million shares. There was a rise of 15.75%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 17, 2025 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $47 price target.
